763 related articles for article (PubMed ID: 8645011)
1. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
Keller RK; Zhao Z; Chambers C; Ness GC
Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
[TBL] [Abstract][Full Text] [Related]
2. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
Ness GC; Zhao Z; Keller RK
Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
[TBL] [Abstract][Full Text] [Related]
3. Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro.
Correll CC; Edwards PA
J Biol Chem; 1994 Jan; 269(1):633-8. PubMed ID: 8276863
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Peffley DM; Gayen AK
Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.
Petras SF; Lindsey S; Harwood HJ
J Lipid Res; 1999 Jan; 40(1):24-38. PubMed ID: 9869647
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
7. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver.
Ness GC; Eales S; Lopez D; Zhao Z
Arch Biochem Biophys; 1994 Feb; 308(2):420-5. PubMed ID: 8109970
[TBL] [Abstract][Full Text] [Related]
8. Compensatory responses to inhibition of hepatic squalene synthase.
Lopez D; Chambers CM; Keller RK; Ness GC
Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
Ness GC; Zhao Z; Lopez D
Arch Biochem Biophys; 1996 Jan; 325(2):242-8. PubMed ID: 8561503
[TBL] [Abstract][Full Text] [Related]
10. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors unmask cryptic regulatory mechanisms.
Lopez D; Chambers CM; Ness GC
Arch Biochem Biophys; 1997 Jul; 343(1):118-22. PubMed ID: 9210653
[TBL] [Abstract][Full Text] [Related]
11. Farnesol as a regulator of HMG-CoA reductase degradation: characterization and role of farnesyl pyrophosphatase.
Meigs TE; Simoni RD
Arch Biochem Biophys; 1997 Sep; 345(1):1-9. PubMed ID: 9281305
[TBL] [Abstract][Full Text] [Related]
12. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Correll CC; Ng L; Edwards PA
J Biol Chem; 1994 Jul; 269(26):17390-3. PubMed ID: 8021239
[TBL] [Abstract][Full Text] [Related]
13. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo.
Meigs TE; Roseman DS; Simoni RD
J Biol Chem; 1996 Apr; 271(14):7916-22. PubMed ID: 8626470
[TBL] [Abstract][Full Text] [Related]
15. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
[TBL] [Abstract][Full Text] [Related]
16. Characterization and regulation of HMG-CoA reductase during a cycle of juvenile hormone synthesis.
Feyereisen R; Farnsworth DE
Mol Cell Endocrinol; 1987 Oct; 53(3):227-38. PubMed ID: 3666299
[TBL] [Abstract][Full Text] [Related]
17. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
[TBL] [Abstract][Full Text] [Related]
18. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase.
Kita T; Brown MS; Goldstein JL
J Clin Invest; 1980 Nov; 66(5):1094-100. PubMed ID: 6903572
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cholesterol 7 alpha-hydroxylase expression by sterols in primary rat hepatocyte cultures.
Doerner KC; Gurley EC; Vlahcevic ZR; Hylemon PB
J Lipid Res; 1995 Jun; 36(6):1168-77. PubMed ID: 7665995
[TBL] [Abstract][Full Text] [Related]
20. In vivo modulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase, reductase kinase, and reductase kinase kinase by mevalonolactone.
Beg ZH; Stonik JA; Brewer HB
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7293-7. PubMed ID: 6594693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
